Preclinical PET Scanner for Simultaneous PET/MRI Installed at the University of Arizona Could Contribute to Improved Tumor Assessment
Dual-modality approach being developed by the University of Arizona uses Cubresa’s NuPET™ PET scanner and a dynamic MRI technique to more fully characterize cancerous tumors. Winnipeg, MB – September 1, 2016 – Cubresa Inc., a medical imaging company that develops and markets molecular imaging systems, today announced the successful installation of their compact PET scanner called NuPET™ for…
BIOTIC and Cubresa continue successful partnership with PET scanner testing
Halifax, NS – August 5, 2016 – BIOTIC (Biomedical Translational Imaging Centre), the advanced imaging center at the IWK Health Centre, has been chosen as the first research facility to test a new preclinical PET (Positron Emission Tomography) scanner. Cubresa, a medical imaging company that develops and markets nuclear imaging systems, has developed NuPET™, a…
Cubresa Booth 207 at WMIC in New York
Cubresa to Exhibit at the WMIC 2016 Annual Congress & Exhibition in New York UPDATE: Congratulations to Patrick Chow of Bristol-Myers Squibb, on winning our custom-engraved Apple® iPad™ Pro in the booth on Saturday. Dr. Chow was selected at random from attendees who participated in our survey. Bookmark this page[1]To bookmark this page, press the Ctrl (PCs)…
Imaging cloak patent could enable more accurate 3D medical imaging
Winnipeg, MB – July 13, 2016 – Instead of a cloak of invisibility hiding a person in television and movies, a new method that describes mounting many imaging sensors underneath a flexible substrate could reveal tumors within humans or animals. Cubresa Inc., a medical imaging company that develops and markets nuclear imaging systems, today announced…
Cubresa Featured in MTS Talks Business Hub Video
A new video on the MTS Talks website features Cubresa Founder and CTO James Schallenberg and CEO George Abe describe their work at Cubresa and their experience doing business in the Manitoba work environment, the healthcare industry and within a supportive community. They also offer some advice to aspiring entrepreneurs. MTS Talks says the two leaders “pack a punch in…
Cubresa Named in Globe & Mail Article on the Diverse, Strong Economy of Winnipeg
In a recent Globe & Mail article “Winnipeg: Canada’s unlikely economic sweet spot”, Cubresa is mentioned as part of an extremely diversified economy that powers the Manitoba provincial economy, an economy that no longer depends on a single natural resource. Cubresa board member, David Asper is quoted in the article. A lawyer and businessman, Asper plays a leading…
NuPET™ Preclinical PET Scanner Released for Simultaneous PET/MRI in Existing MRI Systems
Cubresa’s NuPET™ scanner enables simultaneous preclinical molecular & functional imaging. The PET (Positron Emission Tomography) scanner inserts into existing MRI (Magnetic Resonance Imaging) systems and can speed drug development and clarify disease mechanisms for biomedical researchers. Winnipeg, MB – April 26, 2016 – A compact PET scanner called NuPET™ has been commercially released for simultaneous preclinical…
WMIC 2016 Annual Congress & Exhibition
Cubresa to Exhibit at the WMIC 2016 Annual Congress & Exhibition in New York Come visit us in Booth 207 at the Jacob Javits Convention Center in New York, September 7 to 10, 2016. We will be showcasing our NuPET™ in-bore PET scanner for existing pre-clinical MRI systems. The NuPET scanner enables simultaneous PET and MR imaging within your existing…
SNMMI 2016 Annual Meeting & Exhibition
Cubresa’s NuPET™ arrived at the SNMMI 2016 Annual Meeting & Exhibition in San Diego Reveal disease & therapeutic mechanisms with simultaneous molecular & functional imaging Would you like to be empowered with simultaneous multimodal molecular & functional preclinical imaging? Would you like to combine PET with the soft tissue contrast and functional imaging capabilities of MRI — at…
Cubresa is a world leader in the design and development of clinical and preclinical PET inserts for MRI. Cubresa products enable medical professionals at leading universities, hospitals and pharmaceutical companies to visualize and measure biochemical processes at the molecular level.
Company
About Us
Leadership
Technology
Careers
Location
Cubresa Inc.
800-136 Market Ave
Winnipeg, MB, Canada
R3B 0P4
Products
Clinical:
Preclinical:
Contact
Request more information